DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,714,710 | +2.2% | 10,942 | -1.1% | 0.04% | +5.0% |
| Q2 2023 | $2,655,600 | -4.2% | 11,065 | +0.6% | 0.04% | -11.1% |
| Q1 2023 | $2,772,692 | -4.1% | 11,001 | +1.0% | 0.04% | -10.0% |
| Q4 2022 | $2,891,000 | +3.0% | 10,893 | +0.3% | 0.05% | -3.8% |
| Q3 2022 | $2,806,000 | -0.1% | 10,863 | -2.0% | 0.05% | +6.1% |
| Q2 2022 | $2,810,000 | -16.1% | 11,085 | -3.0% | 0.05% | +2.1% |
| Q1 2022 | $3,351,000 | -12.9% | 11,425 | -2.3% | 0.05% | -9.4% |
| Q4 2021 | $3,848,000 | +6.0% | 11,697 | -1.9% | 0.05% | -7.0% |
| Q3 2021 | $3,630,000 | +14.2% | 11,922 | +0.7% | 0.06% | +11.8% |
| Q2 2021 | $3,178,000 | +14.4% | 11,842 | -4.1% | 0.05% | +6.2% |
| Q1 2021 | $2,779,000 | +0.5% | 12,346 | -0.8% | 0.05% | -2.0% |
| Q4 2020 | $2,766,000 | +6.9% | 12,450 | +3.6% | 0.05% | -3.9% |
| Q3 2020 | $2,588,000 | +19.4% | 12,021 | -1.9% | 0.05% | +6.2% |
| Q2 2020 | $2,167,000 | +31.1% | 12,256 | +2.6% | 0.05% | +11.6% |
| Q1 2020 | $1,653,000 | -11.1% | 11,940 | -1.4% | 0.04% | +2.4% |
| Q4 2019 | $1,859,000 | +6.8% | 12,115 | +0.6% | 0.04% | -2.3% |
| Q3 2019 | $1,740,000 | +0.8% | 12,045 | -0.2% | 0.04% | 0.0% |
| Q2 2019 | $1,726,000 | +0.9% | 12,075 | -6.8% | 0.04% | -2.3% |
| Q1 2019 | $1,710,000 | +27.7% | 12,950 | -0.3% | 0.04% | +15.8% |
| Q4 2018 | $1,339,000 | -4.1% | 12,983 | +1.1% | 0.04% | +8.6% |
| Q3 2018 | $1,396,000 | +24.8% | 12,848 | +13.3% | 0.04% | +16.7% |
| Q2 2018 | $1,119,000 | +3.4% | 11,343 | +2.6% | 0.03% | 0.0% |
| Q1 2018 | $1,082,000 | -71.6% | 11,055 | -73.1% | 0.03% | -71.7% |
| Q4 2017 | $3,813,000 | +24.7% | 41,075 | +15.3% | 0.11% | +15.2% |
| Q3 2017 | $3,057,000 | +3.7% | 35,635 | +2.0% | 0.09% | +1.1% |
| Q2 2017 | $2,947,000 | +78.3% | 34,925 | +80.7% | 0.09% | +68.5% |
| Q1 2017 | $1,653,000 | +641.3% | 19,325 | +575.2% | 0.05% | +575.0% |
| Q4 2016 | $223,000 | +4.7% | 2,862 | +5.5% | 0.01% | 0.0% |
| Q3 2016 | $213,000 | -30.6% | 2,712 | -10.7% | 0.01% | -27.3% |
| Q2 2016 | $307,000 | +6.6% | 3,037 | 0.0% | 0.01% | +10.0% |
| Q1 2016 | $288,000 | +2.1% | 3,037 | 0.0% | 0.01% | 0.0% |
| Q4 2015 | $282,000 | +8.9% | 3,037 | 0.0% | 0.01% | +11.1% |
| Q3 2015 | $259,000 | -7.8% | 3,037 | -7.5% | 0.01% | -10.0% |
| Q2 2015 | $281,000 | +0.7% | 3,282 | 0.0% | 0.01% | 0.0% |
| Q1 2015 | $279,000 | -0.7% | 3,282 | 0.0% | 0.01% | 0.0% |
| Q4 2014 | $281,000 | +12.9% | 3,282 | 0.0% | 0.01% | +11.1% |
| Q3 2014 | $249,000 | -3.5% | 3,282 | 0.0% | 0.01% | -10.0% |
| Q2 2014 | $258,000 | +4.9% | 3,282 | 0.0% | 0.01% | +11.1% |
| Q1 2014 | $246,000 | -2.8% | 3,282 | 0.0% | 0.01% | 0.0% |
| Q4 2013 | $253,000 | +11.0% | 3,282 | 0.0% | 0.01% | 0.0% |
| Q3 2013 | $228,000 | +9.6% | 3,282 | 0.0% | 0.01% | 0.0% |
| Q2 2013 | $208,000 | – | 3,282 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |